for the main comparison.
Sucrose (20% to 33%) compared with water for pain associated with heel lance | |||||
Patient or population: neonates with heel lance‐associated pain Settings: hospital Intervention: sucrose (20% to 33%) Comparison: water | |||||
Outcomes | Illustrative comparative risks (mean and range) | No of participants (studies) | Quality of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | ||||
Water | Sucrose (20% to 33%) | ||||
PIPP at 30 s after heel lance Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA. A lower score = less pain (Stevens 1996) |
The mean for PIPP ranged across control groups from 8.5 to 9.62 | The WMD for PIPP in the intervention groups was lower: ‐1.42 (95% CI ‐2.86 to 0.01) | 105 (2) | ⊕⊕⊝⊝ low | Bias: there were some concerns about bias in both studies (see RoB tables) Consistency: there was moderate inconsistency between the study point estimates (12 = 51 %) Precision: there was low precision in the point estimate with wide 95% CIs) Indirectness: all trials were conducted in the target population (no concern about indirectness) |
PIPP at 60 s after heel lance Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants >3 6 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) |
The mean for PIPP in the control group was 8.59 | The mean for PIPP in the intervention groups was lower: ‐1.80 (95% CI ‐3.81 to 0.21) | 31 (1) |
⊕⊕⊝⊝ low | Bias: there were concerns about allocation concealment and performance bias in this single study Consistency: N/A as there was only one study Precision: there was lack of precision due to small sample size Indirectness: the study was conducted in the target population |
PIPP score during heel lance (1st heel lance) Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) |
The mean for PIPP in the control group was 7.3 | The mean for PIPP in the intervention group was the same as in the control group: 0.00 (95% CI ‐1.52 to 1.52) | 107 (1) | ⊕⊕⊕⊝ moderate | Bias: there were no concerns about bias in this study Consistency: as there was only one study in this analysis concerns about consistency were N/A Precision: this was a relatively large single study (no lack of precision) Indirectness: the study was conducted in the target population |
DAN score at 30 s after heel lance Range of scale 0‐10 A lower score = less pain (Carbajal 1997) |
The mean DAN score in the control group was 9.5 | The mean DAN score in the intervention group was lower: ‐1.90 (95% CI ‐8.58 to 4.78) | 32 (1) | ⊕⊕⊝⊝ low | Bias: concerns about blinding of performance and detection bias Consistency: as there was only one study in this analysis concerns about consistency were not N/A Precision: small sample size Indirectness: the study was conducted in the target population |
NIPS during heel lance Range of scale 0‐7 A lower score = less pain Lawrence 1993 |
The mean NIPS score in the control group was 3 | The mean NIPS score in the intervention group was lower: ‐2.00 (95% CI ‐2.42 to ‐1.58) | 56 (1) |
⊕⊕⊕⊝ moderate | Bias: no concerns about bias Consistency: as there was only one study in this analysis concerns about consistency were N/A Precision: small sample size Indirectness: the study was conducted in the target population (no concern about indirectness) |
*The basis for the assumed risk was 'The mean PIPP, DAN and NIPS scores across control groups according to the values reported in the Assumed risk column. The corresponding risk was the mean in the intervention groups for the PIPP, DAN and NIPS scores with their 95% CI'. CI: confidence interval; DAN: Douleur Aiguë du Nouveau‐né Scale; PIPP: Premature Infant Pain Profile; PMA: postmenstrual age; N/A: not applicable; NIPS: Neonatal Infant Pain Scale; WMD: weighted mean difference | |||||
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. |